Nuvation Bio Inc.
NUVBNYSEHealthcare● Active
$4.89
+$0.07(+1.35%)
Market Cap$1.7B
P/E Ratio—
52W High$9.75
52W Low$1.57
Nuvation Bio Inc. (NUVB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NUVB · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $62.90M | $7.87M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $8.44M | $7.08M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $54.46M | $0.80M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 86.58% | 10.10% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $115.11M | $524.19M | $71.29M | $87.81M | $69.04M |
| G&A Expenses | $0.00M | $66.73M | $28.53M | $31.92M | $24.28M |
| Total Operating Expenses | $267.52M | $593.42M | $99.82M | $119.73M | $93.32M |
| Operating Income | ($213.06M) | ($592.63M) | ($99.82M) | ($119.73M) | ($93.32M) |
| Operating Margin %(computed) | -338.72% | — | — | — | — |
| Interest Income | $21.43M | $27.06M | $24.61M | $7.45M | $2.96M |
| Interest Expense | $13.68M | $0.34M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($204.63M) | ($567.94M) | ($75.80M) | ($104.20M) | ($86.85M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($204.63M) | ($567.94M) | ($75.80M) | ($104.20M) | ($86.85M) |
| Net Margin %(computed) | -325.31% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.60 | $-2.11 | $-0.35 | $-0.48 | $-0.44 |
| Wtd Avg Shares | 341.54M | 268.77M | 218.88M | 216.72M | 197.89M |
| EBITDA | ($190.94M) | ($566.91M) | ($75.58M) | ($119.53M) | ($93.13M) |
| EBITDA Margin %(computed) | -303.56% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Nuvation Bio Inc. data
About Nuvation Bio Inc. (NUVB) Income Statement
Nuvation Bio Inc. (NUVB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NUVB reported revenue of $0.06B, gross profit of $0.05B (gross margin 86.58%), and net income of ($0.20B) — a net profit margin of -325.31%.
Frequently asked questions
NUVB · 4 questionsNuvation Bio Inc. (NUVB) reported revenue of $0.06B for 2025, up 699.0% year-over-year.
NUVB revenueNUVB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08